PAS
PRVA icon

Park Avenue Securities’s Privia Health PRVA Stock Holding History

Park Avenue Securities’s Portfolio PRVA Stock Details PRVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$340K Sell
13,227
-932
-7% -$21.6K ﹤0.01% 1457
2026
Q1 		$291K Sell
14,159
-3,348
-19% -$75.5K ﹤0.01% 1329
2025
Q4 		$415K Buy
17,507
+3,272
+23% +$79.6K ﹤0.01% 1179
2025
Q3 		$354K Sell
14,235
-626
-4% -$13.5K ﹤0.01% 1347
2025
Q2 		$342K Sell
14,861
-368
-2% -$8.52K ﹤0.01% 1229
2025
Q1 		$342K Buy
15,229
+532
+4% +$12.4K ﹤0.01% 969
2024
Q4 		$287K Buy
14,697
+532
+4% +$10.5K ﹤0.01% 1300
2024
Q3 		$258K Sell
14,165
-990
-7% -$18.9K ﹤0.01% 1245
2024
Q2 		$263K Sell
15,155
-343
-2% -$6.08K ﹤0.01% 1230
2024
Q1 		$304K Buy
15,498
+466
+3% +$9.84K ﹤0.01% 1169
2023
Q4 		$346K Buy
15,032
+3,819
+34% +$85.5K ﹤0.01% 1055
2023
Q3 		$258K Sell
11,213
-1,018
-8% -$25.9K ﹤0.01% 1121
2023
Q2 		$319K Buy
+12,231
New +$323K 0.01% 682

Other funds holding PRVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Park Avenue Securities's PRVA Position: Q2 2026 in Review

Park Avenue Securities reduced its Privia Health (PRVA) stake by 6.6% in Q2 2026, selling an estimated $21.6K and leaving 13,227 shares worth $340K. The position accounts for ﹤0.01% of the portfolio, ranked #1457.

Park Avenue Securities first reported a position in PRVA in Q2 2023 and has held it in 13 quarters since. The position peaked at $415K in Q4 2025. 301 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • Park Avenue Securities held 13,227 shares of Privia Health worth $340K as of Q2 2026.
  • Park Avenue Securities sold 932 Privia Health shares in Q2 2026, an estimated $21.6K.
  • Privia Health made up ﹤0.01% of Park Avenue Securities's portfolio in Q2 2026, its #1457 holding.
  • Park Avenue Securities first reported a position in Privia Health in Q2 2023 and has held it in 13 quarters since.
  • Park Avenue Securities's Privia Health position peaked at $415K in Q4 2025.
  • 301 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on Park Avenue Securities's 13F filing for Q2 2026, filed 20 Jul 2026.